Deafness due to a non-MRI-visible endolymphatic sac tumor despite targeted screening
Endolymphatic sac tumours (ELSTs) of the inner ear occur in 16% of patients with the hereditary tumor syndrome von Hippel-Lindau disease (vHL). ELSTs of all sizes can cause irreversible hearing loss which can, however, be prevented through early diagnosis and treatment. We aim to emphasize the challenges of prophylactic ELST screening and to explore the role of audiometry in pre-symptomatic ELST screening.
International Journal of Audiology, 2013, Vol 52, Issue 11, p. 771-775
Case Reports; Journal Article; Research Support, Non-U.S. Gov't